In an online survey of 1,005 Americans, produced by independent creative market research agency Atomik Research, 72% of participants said they will prioritize traveling to see family and friends, with three-fourths agreeing they are likely to do so...
Researchers may have a real shot at creating an oral COVID-19 vaccine, one that can protect against variants. A pill can be self-administered anywhere, anytime providing access to those in remote locations and the most vulnerable who...
Every morning is a chance to seize the day and close the gap between intention and motivation. No one embodies this mentality better than NBA icon, businessman and philanthropist LeBron James, an integral partner behind the launch of...
Citing data from Israel, Pfizer and BioNTech said
their COVID-19 vaccine was 94% effective in preventing asymptomatic infection,
but their announcement lacked key details. These new data build upon and
confirm previously released data from the Israel Ministry of Health...
 The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the...
Pharmaceutical giant, Johnson & Johnson has requested emergency use authorization from the Food and Drug Administration. The company submitted its application Thursday for the company's single-dose inoculation.
In a statement to the press, the...
A new study out of the United Kingdom showed that a single dose of the COVID-19 vaccine developed by Oxford University and AstraZeneca provides a high level of protection for 12 weeks. The study results support the...
For many Americans, living through 2020 has caused a dramatic shift in priorities, with their health, and the health of their loved ones especially, rising to the top as the most important concern. In fact, a nationally...
Prime Minister Boris Johnson announced yesterday a new national lockdown for the UK until at least mid-February to combat a fast-spreading new variant of the coronavirus, even as the UK sped up its vaccination program by becoming...
Rare disease therapy developer, Immusoft, has signed a licensing agreement with Takeda Pharmaceutical with a total potential value of more than $900...
The Prix Galien Awards Committee announced that six world-leading biopharma companies responsible for the development of COVID-19 vaccines and therapeutics will jointly...
